Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


1 Acta Neuropathol
20 Alzheimers Dement
2 Ann Neurol
2 BMC Geriatr
2 Brain
1 Curr Alzheimer Res
1 Exp Neurol
14 J Alzheimers Dis
1 J Neurochem
2 J Neurol Neurosurg Psychiatry
2 J Neurosci
2 Nat Med
1 Nat Neurosci
1 Nature
5 Neurobiol Dis
1 Neurol Clin Pract
3 Neurology
3 Proc Natl Acad Sci U S A

    Acta Neuropathol

  1. FILIPELLO F, You SF, Mirfakhar FS, Mahali S, et al
    Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
    Acta Neuropathol. 2023;145:749-772.
    >> Share

    Alzheimers Dement

  2. LANGBAUM JB, Maloney E, Hennessy M, Harkins K, et al
    How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13126.
    >> Share

  3. EVANS CD, Sparks J, Andersen SW, Brooks DA, et al
    APOE epsilon4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13128.
    >> Share

  4. KARMARKAR AM, Roy I, Rivera-Hernandez M, Shaibi S, et al
    Examining the role of race and quality of home health agencies in delayed initiation of home health services for individuals with Alzheimer's disease and related dementias (ADRD).
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13139.
    >> Share

  5. TUMURBAATAR B, Fracassi A, Scaduto P, Guptarak J, et al
    Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology.
    Alzheimers Dement. 2023 May 16. doi: 10.1002/alz.13074.
    >> Share

  6. OECKL P, Janelidze S, Halbgebauer S, Stomrud E, et al
    Higher plasma beta-synuclein indicates early synaptic degeneration in Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13103.
    >> Share

  7. VASUNILASHORN SM, Lunardi N, Newman JC, Crosby G, et al
    Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network.
    Alzheimers Dement. 2023;19:2150-2174.
    >> Share

  8. DALY T
    Amyloid PET-assisted diagnosis and improved outcomes: Biomarkering or biomarketing?
    Alzheimers Dement. 2023;19:2211.
    >> Share

  9. POLSINELLI AJ, Lane KA, Manchella MK, Logan PE, et al
    APOE epsilon4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Alzheimers Dement. 2023;19:2212-2217.
    >> Share

  10. WOLFF JL, DesRoches CM, Amjad H, Burgdorf JG, et al
    Catalyzing dementia care through the learning health system and consumer health information technology.
    Alzheimers Dement. 2023;19:2197-2207.
    >> Share

  11. JONSDOTTIR MK, Harrison J, Hannesdottir KI
    The ambivalence toward neuropsychology in dementia research, diagnosis, and drug development: Myths and misconceptions.
    Alzheimers Dement. 2023;19:2175-2181.
    >> Share

  12. KISBY GE, Oakes H, Beckett D, Spencer PS, et al
    MGMT, a risk factor for both genetic and environmental forms of dementia.
    Alzheimers Dement. 2023;19:2208-2210.
    >> Share

  13. VAN MAURIK IS, Broulikova HM, Mank A, Bakker ED, et al
    A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.
    Alzheimers Dement. 2023;19:2006-2013.
    >> Share

  14. POLSTERL S, Wachinger C
    Identification of causal effects of neuroanatomy on cognitive decline requires modeling unobserved confounders.
    Alzheimers Dement. 2023;19:1994-2005.
    >> Share

  15. ASHTON NJ, Puig-Pijoan A, Mila-Aloma M, Fernandez-Lebrero A, et al
    Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
    Alzheimers Dement. 2023;19:1913-1924.
    >> Share

  16. WORTHA SM, Frenzel S, Bahls M, Habes M, et al
    Association of spermidine plasma levels with brain aging in a population-based study.
    Alzheimers Dement. 2023;19:1832-1840.
    >> Share

  17. LI M, Li Y, Schindler SE, Yen D, et al
    Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based population.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13125.
    >> Share

  18. SWADDIWUDHIPONG N, Whiteside DJ, Hezemans FH, Street D, et al
    Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases.
    Alzheimers Dement. 2023;19:1752-1763.
    >> Share

  19. KLEINEIDAM L, Wagner M, Guski J, Wolfsgruber S, et al
    Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.
    Alzheimers Dement. 2023;19:2056-2068.
    >> Share

  20. PEROVNIK M, Tang CC, Namias M, Eidelberg D, et al
    Longitudinal changes in metabolic network activity in early Alzheimer's disease.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13137.
    >> Share

  21. BODART-SANTOS V, Pinheiro LS, da Silva-Junior AJ, Froza RL, et al
    Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13134.
    >> Share

    Ann Neurol

  22. ANDRE C, Champetier P, Rehel S, Kuhn E, et al
    Rapid Eye Movement Sleep, Neurodegeneration, and Amyloid Deposition in Aging.
    Ann Neurol. 2023;93:979-990.
    >> Share

  23. HOOSHMAND B, Appold F, Fissler P, Perneczky R, et al
    Markers of vitamin B12 status in relation to cerebrospinal fluid biomarkers of Alzheimer's disease and cognitive performance.
    Ann Neurol. 2023 May 12. doi: 10.1002/ana.26673.
    >> Share

    BMC Geriatr

  24. CANDRIAN C, Burke ES, Kline D, Torke AM, et al
    Experiences of caregiving with Alzheimer's disease in the LGBT community.
    BMC Geriatr. 2023;23:293.
    >> Share

  25. GUNER M, Bas AO, Ceylan S, Kahyaoglu Z, et al
    Dysphagia is closely related to frailty in mild-to-moderate Alzheimer's disease.
    BMC Geriatr. 2023;23:304.
    >> Share


  26. JIANG J, Johnson JCS, Requena-Komuro MC, Benhamou E, et al
    Comprehension of acoustically degraded speech in Alzheimer's disease and primary progressive aphasia.
    Brain. 2023 May 15:awad163. doi: 10.1093.
    >> Share

    Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 18:awad171. doi: 10.1093.
    >> Share

    Curr Alzheimer Res

    The Immunopathy of Alzheimer's Disease: Innate or Adaptive?
    Curr Alzheimer Res. 2023 May 17. doi: 10.2174/1567205020666230517103312.
    >> Share

    Exp Neurol

  29. GHASEMI A, Qaffaripour Z, Tourani M, Saleki K, et al
    The relationship between long non-coding RNAs and Wnt/beta-catenin signaling pathway in the pathogenesis of Alzheimer's disease.
    Exp Neurol. 2023 May 16:114434. doi: 10.1016/j.expneurol.2023.114434.
    >> Share

    J Alzheimers Dis

  30. YAN Y, Wu Y, Xiao G, Wang L, et al
    White Matter Changes as an Independent Predictor of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
    >> Share

  31. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
    Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
    >> Share

  32. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
    Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
    >> Share

  33. MOYAERT P, Beun S, Achten E, Clement P, et al
    Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
    >> Share

  34. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
    Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
    >> Share

  35. LI Y, Chang J, Chen X, Liu J, et al
    Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
    >> Share

  36. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
    Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
    >> Share

  37. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
    Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
    >> Share

  38. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
    >> Share

  39. BLUSZTAJN JK, Slack BE
    Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
    >> Share

  40. ABBATE C
    The Adult Neurogenesis Theory of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
    >> Share

  41. LIN H, Pan T, Wang M, Ge J, et al
    Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
    >> Share

  42. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
    Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
    >> Share

  43. CHENG J, Zheng H, Liu C, Jin J, et al
    Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
    >> Share

    J Neurochem

  44. FLEEMAN RM, Kuhn MK, Chan DC, Proctor EA, et al
    Apolipoprotein E epsilon4 modulates astrocyte neuronal support functions in the presence of amyloid-beta.
    J Neurochem. 2023;165:536-549.
    >> Share

    J Neurol Neurosurg Psychiatry

  45. LEHMANN S, Schraen-Maschke S, Vidal JS, Delaby C, et al
    Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
    J Neurol Neurosurg Psychiatry. 2023;94:411-419.
    >> Share

  46. COULTHARD E, Hosseini AA
    Blood biomarkers: ready for clinical practice?
    J Neurol Neurosurg Psychiatry. 2023;94:409-410.
    >> Share

    J Neurosci

  47. BRYANT A, Li Z, Jayakumar R, Serrano-Pozo A, et al
    Endothelial Cells are Heterogeneous in Different Brain Regions and are Dramatically Altered in Alzheimer's Disease.
    J Neurosci. 2023 May 17:JN-RM-0237-23. doi: 10.1523/JNEUROSCI.0237-23.2023.
    >> Share

  48. WALKER CK, Greathouse KM, Tuscher JJ, Dammer EB, et al
    Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.
    J Neurosci. 2023;43:3764-3785.
    >> Share

    Nat Med

  49. LJUBENKOV PA, Rabinovici GD
    Silencing tau to treat early Alzheimer's disease.
    Nat Med. 2023 May 17. doi: 10.1038/s41591-023-02357.
    >> Share

  50. LOPERA F, Marino C, Chandrahas AS, O'Hare M, et al
    Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.
    Nat Med. 2023 May 15. doi: 10.1038/s41591-023-02318.
    >> Share

    Nat Neurosci

  51. CALAFATE S, Ozturan G, Thrupp N, Vanderlinden J, et al
    Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer's disease.
    Nat Neurosci. 2023 May 15. doi: 10.1038/s41593-023-01325.
    >> Share


    How one man's rare Alzheimer's mutation delayed the onset of disease.
    Nature. 2023 May 15. doi: 10.1038/d41586-023-01610.
    >> Share

    Neurobiol Dis

  53. DE FLORES R, Demeilliez-Servouin S, Kuhn E, Chauveau L, et al
    Respective influence of beta-amyloid and APOE epsilon4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
    Neurobiol Dis. 2023;181:106127.
    >> Share

  54. MABROUK R, Miettinen PO, Tanila H
    Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
    Neurobiol Dis. 2023;182:106150.
    >> Share

  55. MUSAEUS CS, Frederiksen KS, Andersen BB, Hogh P, et al
    Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring.
    Neurobiol Dis. 2023 May 15:106149. doi: 10.1016/j.nbd.2023.106149.
    >> Share

  56. DUWAT C, Leal P, Vautheny A, Auregan G, et al
    Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathology.
    Neurobiol Dis. 2023;181:106116.
    >> Share

  57. PEDERSEN TJ, Keil SA, Han W, Wang MX, et al
    The effect of aquaporin-4 mis-localization on Abeta deposition in mice.
    Neurobiol Dis. 2023;181:106100.
    >> Share

    Neurol Clin Pract

  58. WENNBERG A, Ding M, Feychting M, Modig K, et al
    Risk of All-Cause Dementia, Alzheimer Disease, and Vascular Dementia in Breast Cancer Survivors: A Longitudinal Register-Based Study.
    Neurol Clin Pract. 2023;13:e200173.
    >> Share


  59. LUO J, Ma Y, Agboola FJ, Grant E, et al
    Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207378.
    >> Share

  60. DU J, Li A, Shi D, Chen X, et al
    Association of APOE4, Osteoarthritis, beta-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease.
    Neurology. 2023 May 15:10.1212/WNL.0000000000207369.
    >> Share

  61. ALVES F, Kalinowski P, Ayton S
    Accelerated Brain Volume Loss Caused by Anti-beta-Amyloid Drugs: A Systematic Review and Meta-analysis.
    Neurology. 2023;100:e2114-e2124.
    >> Share

    Proc Natl Acad Sci U S A

  62. GHOSH S, Tugarinov V, Clore GM
    Quantitative NMR analysis of the mechanism and kinetics of chaperone Hsp104 action on amyloid-beta42 aggregation and fibril formation.
    Proc Natl Acad Sci U S A. 2023;120:e2305823120.
    >> Share

  63. MILLER A, Wei J, Meehan S, Dobson CM, et al
    Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains.
    Proc Natl Acad Sci U S A. 2023;120:e2216234120.
    >> Share

  64. CHEN W, Huang Q, Lazdon EK, Gomes A, et al
    Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model.
    Proc Natl Acad Sci U S A. 2023;120:e2220684120.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016